EYEGATE PHARMACEUTICALS INC's ticker is EYEGW and the CUSIP is 30233M115. A total of 5 filers reported holding EYEGATE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $6,000 | +50.0% | 137,092 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $4,000 | -42.9% | 137,092 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $7,000 | +133.3% | 137,092 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $3,000 | +50.0% | 137,092 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -33.3% | 137,092 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $3,000 | -62.5% | 137,092 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $8,000 | +14.3% | 137,092 | 0.0% | 0.00% | +100.0% |
| Q3 2018 | $7,000 | -41.7% | 137,092 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $12,000 | 0.0% | 137,092 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | -42.9% | 137,092 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $21,000 | +31.2% | 137,092 | 0.0% | 0.00% | +33.3% |
| Q3 2017 | $16,000 | +45.5% | 137,092 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $11,000 | -73.8% | 137,092 | -50.0% | 0.00% | -50.0% |
| Q1 2017 | $42,000 | +2.4% | 274,184 | +100.0% | 0.00% | -50.0% |
| Q4 2016 | $41,000 | -14.6% | 137,092 | 0.0% | 0.01% | -11.1% |
| Q3 2016 | $48,000 | -44.2% | 137,092 | 0.0% | 0.01% | -50.0% |
| Q2 2016 | $86,000 | -16.5% | 137,092 | 0.0% | 0.02% | -18.2% |
| Q1 2016 | $103,000 | 0.0% | 137,092 | 0.0% | 0.02% | +10.0% |
| Q4 2015 | $103,000 | -26.4% | 137,092 | 0.0% | 0.02% | -25.9% |
| Q3 2015 | $140,000 | – | 137,092 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 137,092 | $7,000 | 0.00% |
| CVI Holdings, LLC | 12,900 | $0 | 0.00% |
| UBS Group AG | 4,300 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |